Treatment of Acute Rheumatic Fever
The treatment of acute rheumatic fever requires both antimicrobial therapy to eradicate Group A Streptococcus and anti-inflammatory therapy to manage symptoms, followed by long-term prophylaxis to prevent recurrences.
Primary Treatment Components
1. Antimicrobial Therapy
Eradication of Group A Streptococcal (GAS) infection is essential, even if throat cultures are negative at the time of diagnosis:
First-line therapy: Intramuscular benzathine penicillin G as a single injection 1
- Children ≤27 kg: 600,000 units
- Children >27 kg, adolescents, and adults: 1,200,000 units
Alternative oral therapy: 10-day course of penicillin V 1, 2
- Children: 250 mg 2-3 times daily
- Adolescents and adults: 500 mg 2-3 times daily
For penicillin-allergic patients (non-anaphylactic reactions):
2. Anti-inflammatory Therapy
For rheumatic carditis: Prednisone is indicated for acute rheumatic carditis 3
- Dosing should be based on severity of inflammation and cardiac involvement
For arthritis: Salicylates or other NSAIDs until symptoms resolve
- Continue for 2-3 weeks for arthritis symptoms
3. Supportive Care
- Bed rest for patients with carditis until inflammation subsides
- Cardiac monitoring for patients with severe carditis
- Management of heart failure if present
Secondary Prophylaxis
Secondary prophylaxis is crucial to prevent recurrences and must be initiated immediately after completing the treatment for acute episode:
Preferred regimen: Intramuscular benzathine penicillin G 1, 4, 5
Alternative oral regimen: Penicillin V 250 mg twice daily 1, 7
- Note: Intramuscular regimen is more effective than oral regimen 5
For penicillin-allergic patients: Sulfadiazine or sulfisoxazole 1
- ≤27 kg: 500 mg once daily
27 kg: 1 g once daily
Duration of Secondary Prophylaxis
The duration depends on the presence of carditis and residual heart disease:
With carditis and persistent valvular disease: Continue for 10 years after last episode or until age 40, whichever is longer; consider lifelong prophylaxis for high-risk patients 1
With carditis but no persistent valvular disease: Continue for 10 years or until age 21, whichever is longer 1
Without carditis: Continue until age 21 or for 5 years after the last attack, whichever is longer 1
Important Considerations
- Compliance with secondary prophylaxis is critical for preventing recurrences
- Regular cardiac follow-up is essential for patients with rheumatic heart disease
- Studies show that 3-weekly benzathine penicillin G injections are more effective than 4-weekly regimens in preventing recurrences 4, 6, 8
- Serum penicillin levels may fall below protective levels before the fourth week after administration 1, 7
Pitfalls to Avoid
- Inadequate duration of antimicrobial therapy (must complete full course)
- Premature discontinuation of secondary prophylaxis
- Failure to monitor for cardiac complications
- Inadequate patient education about the importance of adherence to prophylaxis
- Overlooking the need for more frequent (3-weekly) prophylaxis in high-risk patients
Regular follow-up is essential to monitor for recurrences, assess cardiac status, and ensure compliance with prophylaxis.